The number of instances of food allergies and food intolerances is growing and many of the symptoms manifest in digestive disorders and discomfort. Because this is a growing health concern for many, we are committed to supporting biopharmaceutical studies for gastrointestinal disorders.
Chiltern has a team of gastroenterologists and other medical professionals who are familiar with the oversight and treatment of gastroenterology disorders — adding support and value to your project with their expertise and leadership. Working as a cross-functional group, the team collaborates with you to provide advice from medical, operational, regulatory and cost-efficiency perspectives. Our staff has the clinical expertise, global experience and resources necessary to understand the complex and ever-changing treatment protocols and ensure patient compliance, leading to better patient experiences, improved clinical outcomes and expedited regulatory approvals.
Over the last five years, Chiltern has conducted 71 gastroenterology studies.
Top Gastroenterology Indications From the Past Five Years
- Anal fissure
- Clostridium difficile infection
- Crohn’s disease
- Gastroesophageal reflux disease (GERD)
- Inflammatory bowel disease
- Irritable bowel syndrome
- Liver disorder
- Liver fibrosis
- Oral mucositis
- Parenteral nutrition
- Primary biliary cirrhosis
- Ulcerative colitis